CollPlant Biotechnologies CLGN
NASDAQ CLGN
$0.31 +0.01 (+4.06%)
As of: Aug 21, 2026 · 3:59 PM EDT

CollPlant Biotechnologies (CLGN) Assets Growth (5y) (2022 - 2025)

CollPlant Biotechnologies (CLGN) Assets Growth (5y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 CollPlant Biotechnologies 4.26 Mn 4.26 Mn -243,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.10%
Sep 30, 2025 1.98%
Jun 30, 2025 9.76%
Dec 31, 2024 11.72%
Sep 30, 2024 -71.92%
Jun 30, 2024 22.71%
Mar 31, 2024 -69.59%
Dec 31, 2023 31.28%
Sep 30, 2023 -63.98%
Jun 30, 2023 46.04%
Mar 31, 2023 7.67%
Dec 31, 2022 36.10%